For decades, Mauritius has figured among the top 10 countries with the highest incidence of type 2 diabetes (T2D). 29% of all deaths is directly linked to T2D, ranking the island as number two worldwide for diabetes-associated deaths. Among children aged 5-18 years, 22% are overweight, with elevated blood glucose levels. Due to its unique multi-ethnic population (of Indian, African, Chinese and Caucasian background) and compelling disease profile, Mauritius represents a fresh model for clinical research in T2D and related co-morbidities.

The presentation describes the local diseases and abundance of drug-naïve patients, the legal regulatory framework for conducting clinical studies, and the competence and infrastructure of the island for participating in multi-centric studies. We will also discuss the support that CIDP can offer as a CRO in facilitating clinical trials in Mauritius.

Latest News
  • 04 December 2019 Dr. Veronique Newton presented “Effects of environment stressors on skin ageing” at the 10th Jean-Paul Marty days
  • 27 November 2019 Meet us in Paris on the 3rd and 4th December for the 10th Jean-Paul Marty days
  • 25 November 2019 CIDP marked World Diabetes Day 2019 with a bang!

Time Zone

Choose a centre